Profile
Full Name
Ascendis Pharma A/STicker
NASDAQ: ASNDExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
DenmarkIPO
January 28, 2015Indexes
Not includedWebsite
https://ascendispharma.comEmployees
1017Key Details
Price
$198.32(+3.27%)
Market cap
$12.13B(Large cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$393.35M(+36.41% YoY)
Annual EPS
-$7.06(+23.59% YoY)
Next earnings date
Nov 6, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Ascendis Pharma A/S doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Aug 8, 25 Wells Fargo
OverweightAug 8, 25 Wedbush
OutperformAug 8, 25 UBS
BuyAug 8, 25 Stifel
BuyAug 8, 25 RBC Capital
OutperformAug 8, 25 Citigroup
BuyAug 8, 25 Cantor Fitzgerald
OverweightJul 29, 25 JP Morgan
OverweightJul 11, 25 Citigroup
BuyJun 13, 25 Oppenheimer
OutperformInstitutional Ownership
- What is the ticker symbol for Ascendis Pharma A/S?
- Does Ascendis Pharma A/S pay dividends?
- What sector is Ascendis Pharma A/S in?
- What industry is Ascendis Pharma A/S in?
- What country is Ascendis Pharma A/S based in?
- When did Ascendis Pharma A/S go public?
- Is Ascendis Pharma A/S in the S&P 500?
- Is Ascendis Pharma A/S in the NASDAQ 100?
- Is Ascendis Pharma A/S in the Dow Jones?
- When was Ascendis Pharma A/S's last earnings report?
- When does Ascendis Pharma A/S report earnings?
What is the ticker symbol for Ascendis Pharma A/S?
The ticker symbol for Ascendis Pharma A/S is NASDAQ:ASND
Does Ascendis Pharma A/S pay dividends?
No, Ascendis Pharma A/S does not pay dividends
What sector is Ascendis Pharma A/S in?
Ascendis Pharma A/S is in the Healthcare sector
What industry is Ascendis Pharma A/S in?
Ascendis Pharma A/S is in the Biotechnology industry
What country is Ascendis Pharma A/S based in?
Ascendis Pharma A/S is headquartered in Denmark
When did Ascendis Pharma A/S go public?
Ascendis Pharma A/S's initial public offering (IPO) was on January 28, 2015
Is Ascendis Pharma A/S in the S&P 500?
No, Ascendis Pharma A/S is not included in the S&P 500 index
Is Ascendis Pharma A/S in the NASDAQ 100?
No, Ascendis Pharma A/S is not included in the NASDAQ 100 index
Is Ascendis Pharma A/S in the Dow Jones?
No, Ascendis Pharma A/S is not included in the Dow Jones index
When was Ascendis Pharma A/S's last earnings report?
Ascendis Pharma A/S's most recent earnings report was on August 7, 2025
When does Ascendis Pharma A/S report earnings?
The next expected earnings date for Ascendis Pharma A/S is November 6, 2025